A4Cell has developed SPAchip®, a technology that responds to one of the technological challenges we face today: to fully understand cell physiology.
A4Cell has raised €4.3M across 2 funding rounds from 6 investors, most recently a round in Nov 2023. Based in Madrid, Spain; active in Deeptech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-11-16 | Other | €3.0M | Dreavent,BeAble Capital,CDTI Innvierte | View deal → |
| 2021-12-21 | Other | €1.3M | Innvierte Economía Sostenible Sicc Sme ,Beable Capital SGEIC,Ideas de Bomberos SL | View deal → |
